These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update]. Pengo V; De Caterina R Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834 [TBL] [Abstract][Full Text] [Related]
6. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?]. Selçuk H; Selçuk MT; Maden O Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079 [TBL] [Abstract][Full Text] [Related]
7. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]
8. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
9. [When not to prescribe chronic treatment to the patient with atrial fibrillation]. Scardi S; Mazzone C G Ital Cardiol; 1999 Nov; 29(11):1378-80. PubMed ID: 10609146 [No Abstract] [Full Text] [Related]
11. Oral anticoagulation in patients aged 75 years or older with chronic non-valvar atrial fibrillation: effectiveness and safety in daily clinical practice. Ruiz Ortiz M; Romo Peñas E; Franco Zapata MF; Mesa Rubio D; Anguita Sánchez M; López Granados A; Arizón del Prado JM; Vallés Belsué F Heart; 2005 Sep; 91(9):1225-6. PubMed ID: 16103572 [No Abstract] [Full Text] [Related]
12. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. Hu D; Sun Y J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352 [No Abstract] [Full Text] [Related]
13. A promising advance in anticoagulant therapy for patients with atrial fibrillation. Olsson SB Ital Heart J; 2004 May; 5(5):335-9. PubMed ID: 15185895 [No Abstract] [Full Text] [Related]
14. [Prevention of thromboembolism in heart infarct, cardiomyopathy and atrial fibrillation]. Straub PW Schweiz Med Wochenschr; 1990 Mar; 120(11):365-71. PubMed ID: 2181642 [TBL] [Abstract][Full Text] [Related]
15. Aspirin for atrial fibrillation. Douglas M; Strelnick A J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329 [No Abstract] [Full Text] [Related]
16. [What anticoagulant therapy should be used for what form of atrial fibrillation?]. Frantz E Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997 [No Abstract] [Full Text] [Related]
17. [Optimal treatment with oral anticoagulants]. Prins MH; ten Cate JW Ned Tijdschr Geneeskd; 1996 May; 140(20):1059-61. PubMed ID: 8692321 [No Abstract] [Full Text] [Related]
18. Anticoagulation in patients with atrial fibrillation and congestive heart failure. Veloso HH; de Paola AA Am J Cardiol; 2005 Jun; 95(12):1533. PubMed ID: 15950594 [No Abstract] [Full Text] [Related]
19. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation]. Tebbe U Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745 [No Abstract] [Full Text] [Related]
20. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Diner BM Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695 [No Abstract] [Full Text] [Related] [Next] [New Search]